Atlanta Braves (BATRA) Financials

$44.54 -0.02 (-0.04%)

As of 05/20/2025 04:00 PM Eastern

Annual Income Statements for Atlanta Braves

This table shows Atlanta Braves' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-2,063	761	1,815	398	-1,421	106	531	1,354	-4,038	-
Consolidated Net Income / (Loss)	-2,475	962	2,029	744	-1,391	347	865	1,890	-3,550	-
Net Income / (Loss) Continuing Operations	-63	-24	909	744	-1,391	347	847	1,786	-3,550	-
Total Pre-Tax Income	-24	-25	707	789	-1,435	513	1,041	827	-3,550	-
Total Operating Income	276	255	145	1,977	177	1,470	1,511	1,394	-3,578	-
Total Gross Profit	1,165	1,332	1,411	5,943	4,810	5,471	4,459	4,273	-3,988	-
Total Revenue	3,653	3,572	3,161	11,400	9,363	10,292	8,040	7,594	0.00	-
Operating Revenue	3,653	3,572	3,161	11,400	9,363	10,292	8,040	7,594	-	-
Total Cost of Revenue	2,488	2,240	1,750	5,457	4,553	4,821	3,581	3,321	3,988	-
Operating Cost of Revenue	2,488	2,240	1,750	5,457	4,553	4,821	3,581	3,321	3,988	-
Total Operating Expenses	889	1,077	1,266	3,966	4,633	4,001	2,945	2,879	-410	-
Selling, General & Admin Expense	419	396	393	2,232	2,112	2,232	1,649	1,646	612	-
Depreciation Expense	352	406	433	1,072	1,083	1,061	905	824	-	-
Other Operating Expenses / (Income)	13	274	434	642	434	624	391	409	-	-
Impairment Charge	105	1.00	6.00	-	0.00	0.00	-	-	-	-
Total Other Income / (Expense), net	-300	-280	562	-1,188	-1,612	-957	-470	-567	28	-
Interest Expense	237	248	186	642	634	657	606	591	-	-
Interest & Investment Income	-383	-167	524	-451	-402	-315	40	-88	28	-
Other Income / (Expense), net	320	203	205	-95	-576	15	78	8.00	-	-
Income Tax Expense	39	-1.00	-202	45	-44	166	176	-1,063	-	-
Net Income / (Loss) Discontinued Operations	-2,412	986	1,120	-	-	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-412	201	227	346	30	241	334	536	488	-
Weighted Average Basic Shares Outstanding	341.10M	652.95M	613.48M	617.67M	622.12M	598.17M	605.44M	-	586.70M	338M
Weighted Average Diluted Shares Outstanding	341.10M	652.95M	613.48M	617.67M	622.12M	598.17M	605.44M	-	586.70M	338M
Weighted Average Basic & Diluted Shares Outstanding	341.10M	652.95M	613.48M	617.67M	622.12M	598.17M	605.44M	-	586.70M	338M

This table shows Atlanta Braves' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-672	-355	-2,368	457	203	908	-415	253	15	562	391
Consolidated Net Income / (Loss)	-672	-357	-2,870	507	245	1,022	-415	303	52	625	434
Net Income / (Loss) Continuing Operations	-672	-973	132	507	271	-835	456	303	52	-495	434
Total Pre-Tax Income	-672	-1,098	135	623	316	736	-1,230	367	102	-1,111	564
Total Operating Income	-672	-861	107	528	502	622	-1,230	523	340	-1,380	506
Total Gross Profit	-650	-1,994	316	1,410	1,433	-426	-1,230	1,662	1,326	-3,363	1,712
Total Revenue	0.00	-3,173	911	3,166	2,749	-2,228	0.00	3,244	2,556	-5,913	3,247
Total Cost of Revenue	650	-1,179	595	1,756	1,316	-1,802	1,230	1,582	1,230	-2,550	1,535
Operating Cost of Revenue	650	-1,179	595	1,756	1,316	-1,802	1,230	1,582	1,230	-2,550	1,535
Total Operating Expenses	22	-1,107	209	882	905	-1,048	0.00	1,139	986	-1,983	1,206
Restructuring Charge	22	-	-	15	22	-	-	19	32	-	74
Total Other Income / (Expense), net	0.00	-237	28	95	-186	114	0.00	-156	-238	269	58
Net Income / (Loss) Discontinued Operations	0.00	-	-3,002	-	-	-	815	-	-	-	-
Weighted Average Basic Shares Outstanding	341.29M	341.10M	340.44M	654.64M	653.45M	652.95M	652.83M	561.13M	614.08M	613.48M	613.15M
Weighted Average Diluted Shares Outstanding	341.29M	341.10M	340.44M	654.64M	653.45M	652.95M	652.83M	561.13M	614.08M	613.48M	613.15M
Weighted Average Basic & Diluted Shares Outstanding	341.29M	341.10M	340.44M	654.64M	653.45M	652.95M	652.83M	561.13M	614.08M	613.48M	613.15M

This table details how cash moves in and out of Atlanta Braves' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	935	-248	-648	47	1,571	854	-595	471	361	-
Net Cash From Operating Activities	553	634	578	2,437	1,730	2,313	2,156	1,732	2,171	-
Net Cash From Continuing Operating Activities	553	634	578	2,437	1,730	2,313	2,155	1,732	2,171	-
Net Income / (Loss) Continuing Operations	-63	-24	909	744	-1,391	347	865	1,890	924	-
Consolidated Net Income / (Loss)	-2,475	962	2,029	744	-1,391	347	865	1,890	924	-
Net Income / (Loss) Discontinued Operations	-2,412	986	1,120	-	-	-	-	-	-	-
Depreciation Expense	352	406	433	1,072	1,083	1,061	905	824	354	-
Non-Cash Adjustments To Reconcile Net Income	300	96	-720	861	2,201	679	285	263	580	-
Changes in Operating Assets and Liabilities, net	-36	156	-44	-256	-180	217	101	-1,261	302	-
Net Cash From Investing Activities	-187	-544	447	-689	-736	314	-370	-3,137	-1,264	-
Net Cash From Continuing Investing Activities	-187	-544	447	-689	-736	314	-370	-3,137	-1,264	-
Purchase of Property, Plant & Equipment	-75	-461	-309	-440	-452	-510	-403	-517	-568	-
Acquisitions	-205	0.00	0.00	-14	-300	313	-2.00	-1,754	0.00	-
Purchase of Investments	-11	-176	-57	-252	-113	-29	-414	-862	-1,042	-
Sale of Property, Plant & Equipment	117	111	101	383	13	442	399	21	62	-
Sale and/or Maturity of Investments	1.00	0.00	37	40	105	23	64	0.00	273	-
Other Investing Activities, net	-14	-18	675	-406	11	75	-14	-25	11	-
Net Cash From Financing Activities	894	-285	-1,437	-1,698	574	-1,773	-2,380	1,876	-546	-
Net Cash From Continuing Financing Activities	894	-285	-1,437	-1,698	574	-1,773	-2,380	1,876	-546	-
Repayment of Debt	-673	-982	-4,728	-6,394	-3,021	-4,912	-4,028	-5,155	-1,746	-
Repurchase of Preferred Equity	0.00	0.00	-579	0.00	-	-	-	0.00	-	-
Repurchase of Common Equity	0.00	0.00	-37	-2,078	-1,873	-2,602	-1,780	-1,409	-1,674	-
Issuance of Debt	645	1,165	3,289	6,411	4,898	6,020	3,617	6,697	2,745	-
Issuance of Common Equity	939	0.00	0.00	575	634	-211	-130	1,938	203	-
Other Financing Activities, net	-17	-468	618	-154	-	0.00	-	-135	-58	-
Effect of Exchange Rate Changes	-10	1.00	0.00	-3.00	3.00	-	-1.00	-	-	-
Other Net Changes in Cash	-315	-54	-236	-	-	-	-	-	-	-

This table details how cash moves in and out of Atlanta Braves' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	191	-98	952	418	-337	-92	129	-276	-9.00	-289	-154
Net Cash From Operating Activities	381	-23	-571	752	395	54	-618	537	661	-1,162	519
Net Cash From Continuing Operating Activities	381	-23	-571	752	395	54	-618	537	661	-1,162	519
Net Income / (Loss) Continuing Operations	5.00	-357	-458	507	245	-65	-314	303	52	-495	434
Consolidated Net Income / (Loss)	5.00	-357	-2,870	507	245	164	443	303	52	625	434
Net Income / (Loss) Discontinued Operations	0.00	-	-	-	-	229	-	-	-	-	-
Depreciation Expense	77	89	-223	245	241	115	-226	257	260	-357	268
Non-Cash Adjustments To Reconcile Net Income	-63	405	-65	-150	110	186	-240	28	122	-236	-257
Changes in Operating Assets and Liabilities, net	363	-160	175	150	-201	-182	162	-51	227	-74	74
Net Cash From Discontinued Operating Activities	0.00	-	-	-	-	-	-	-	-	-	-
Net Cash From Investing Activities	-181	-15	578	-100	-650	-119	286	-296	-415	953	-131
Net Cash From Continuing Investing Activities	-181	-15	578	-100	-650	-119	286	-296	-415	953	-131
Purchase of Property, Plant & Equipment	-33	-23	335	-186	-201	-118	201	-263	-281	246	-100
Acquisitions	-131	-	-	-	-205	-	-	-	0.00	136	1.00
Purchase of Investments	-6.00	-1.00	193	-23	-180	-3.00	41	-45	-169	-16	-32
Other Investing Activities, net	-11	-2.00	50	2.00	-64	2.00	-	-21	1.00	598	-1.00
Net Cash From Discontinued Investing Activities	0.00	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-13	-49	1,251	-226	-82	-9.00	498	-517	-257	143	-537
Net Cash From Continuing Financing Activities	-13	-49	1,251	-226	-82	-9.00	498	-517	-257	143	-537
Repayment of Debt	-13	-33	965	-1,334	-271	-2.00	1,598	-945	-1,633	-862	-1,182
Net Cash From Discontinued Financing Activities	0.00	-	-	-	-	-	-	-	-	-	-
Other Net Changes in Cash	4.00	-	-	-	-	-19	-	-	-	-	-

This table presents Atlanta Braves' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	12,948	41,327	42,464	44,351	44,004	44,189	40,828	41,996	-	29,798
Total Current Assets	3,347	3,377	3,851	4,812	4,030	2,405	1,082	1,743	-	691
Cash & Equivalents	2,956	1,713	2,246	2,814	2,831	1,222	358	1,029	-	201
Accounts Receivable	114	123	837	828	823	767	364	358	-	247
Other Current Assets	277	180	768	1,170	376	416	360	356	-	243
Other Current Nonoperating Assets	0.00	1,361	-	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	810	838	2,255	2,010	2,239	2,262	2,469	2,541	-	1,879
Plant, Property & Equipment, gross	1,007	973	4,481	4,027	4,017	3,780	3,765	3,596	-	2,587
Accumulated Depreciation	197	135	2,226	2,017	1,778	1,518	1,296	1,055	-	708
Total Noncurrent Assets	8,791	37,112	36,358	37,529	37,735	39,522	37,277	37,712	-	27,228
Long-Term Investments	491	374	952	945	1,018	1,625	1,641	2,864	-	1,648
Goodwill	4,134	3,956	19,341	19,248	19,218	19,939	18,386	18,383	-	14,345
Intangible Assets	2,689	2,858	14,254	14,782	15,363	15,945	15,389	15,866	-	10,770
Noncurrent Deferred & Refundable Income Taxes	760	772	-	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	717	612	1,811	2,554	2,136	2,013	1,861	599	-	465
Other Noncurrent Nonoperating Assets	0.00	28,540	-	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	12,948	41,327	42,464	44,351	44,004	44,189	40,828	41,996	-	29,798
Total Liabilities	5,897	21,882	23,338	25,514	24,403	22,264	19,130	19,422	-	11,667
Total Current Liabilities	1,133	4,743	5,410	6,610	4,490	3,888	3,244	3,979	-	2,813
Short-Term Debt	26	106	1,679	2,891	743	60	17	768	-	255
Accounts Payable	648	474	1,856	1,832	1,583	1,621	1,116	1,250	-	758
Current Deferred Revenue	267	247	1,773	1,790	2,070	2,113	2,079	1,941	-	1,797
Other Current Liabilities	192	40	102	97	94	94	32	20	-	3.00
Other Current Nonoperating Liabilities	0.00	3,876	-	-	-	-	-	-	-	-
Total Noncurrent Liabilities	4,764	17,139	17,928	18,904	19,913	18,376	15,886	15,443	-	8,854
Long-Term Debt	4,522	4,117	14,953	15,699	16,686	15,416	13,371	13,186	-	6,626
Other Noncurrent Operating Liabilities	242	188	874	987	1,101	1,047	864	779	-	561
Other Noncurrent Nonoperating Liabilities	0.00	12,834	-	-	-	0.00	0.00	0.00	-	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Total Equity & Noncontrolling Interests	7,051	19,445	19,126	18,262	19,601	21,925	21,698	22,574	-	18,131
Total Preferred & Common Equity	7,029	16,396	15,963	14,672	15,091	16,295	16,595	16,943	-	10,933
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Total Common Equity	7,029	16,396	15,963	14,672	15,091	16,295	16,595	16,943	-	10,933
Common Stock	3.00	1,323	1,413	1,959	2,693	2,580	2,989	3,897	-	3.00
Retained Earnings	7,179	15,061	14,589	12,718	12,320	13,748	13,644	13,081	-	10,981
Accumulated Other Comprehensive Income / (Loss)	-153	12	-39	-5.00	78	-33	-38	-35	-	-51
Noncontrolling Interest	22	3,049	3,163	3,590	4,510	5,630	5,103	5,631	-	7,198

This table presents Atlanta Braves' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	13,285	13,208	42,632	42,405	41,515	42,442	42,333	43,235
Total Current Assets	3,667	3,679	3,639	3,195	3,625	3,534	3,636	3,970
Cash & Equivalents	3,147	3,054	2,085	1,666	2,112	1,931	2,229	2,542
Accounts Receivable	144	122	826	789	808	822	701	826
Other Current Assets	376	503	728	740	705	781	706	602
Plant, Property, & Equipment, net	825	827	2,123	2,129	2,005	2,557	2,417	2,182
Plant, Property & Equipment, gross	1,039	1,010	4,290	4,183	3,957	4,759	4,563	4,329
Accumulated Depreciation	214	183	2,167	2,054	1,952	2,202	2,146	2,147
Total Noncurrent Assets	8,793	8,702	36,870	37,081	35,885	36,351	36,280	37,083
Long-Term Investments	510	483	1,983	1,996	1,145	1,126	993	1,028
Goodwill	4,134	4,192	19,400	19,399	19,165	19,341	19,341	19,341
Intangible Assets	2,632	2,757	13,670	13,731	13,783	14,025	14,137	14,372
Noncurrent Deferred & Refundable Income Taxes	788	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	729	1,270	1,817	1,955	1,792	1,859	1,809	2,342
Total Liabilities & Shareholders' Equity	13,285	13,208	42,632	42,405	41,515	42,442	42,333	43,235
Total Liabilities	6,226	5,749	22,425	22,760	22,276	23,163	23,249	24,191
Total Current Liabilities	1,446	1,273	4,472	4,866	4,676	4,793	4,592	4,164
Short-Term Debt	30	76	685	1,185	827	787	706	499
Accounts Payable	330	404	1,768	1,621	1,715	1,754	1,613	1,640
Current Deferred Revenue	1,009	756	1,840	1,826	2,024	2,153	2,153	1,930
Other Current Liabilities	77	37	179	234	110	99	120	95
Total Noncurrent Liabilities	4,780	4,476	17,953	17,894	17,600	18,370	18,657	20,027
Long-Term Debt	4,534	4,289	14,343	14,257	14,836	15,432	15,690	17,066
Other Noncurrent Operating Liabilities	246	187	1,400	1,435	724	880	879	868
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	7,059	7,459	20,207	19,645	19,239	19,279	19,084	18,466
Total Preferred & Common Equity	7,037	7,436	17,060	16,551	16,247	16,284	15,962	15,334
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	7,037	7,436	17,060	16,551	16,247	16,284	15,962	15,334
Common Stock	3.00	3.00	1,393	1,341	1,304	1,474	1,400	1,372
Retained Earnings	7,182	7,520	15,724	15,267	14,953	14,857	14,604	14,004
Accumulated Other Comprehensive Income / (Loss)	-148	-87	-57	-57	-10	-47	-42	-42
Noncontrolling Interest	22	23	3,147	3,094	2,992	2,995	3,122	3,132

This table displays calculated financial ratios and metrics derived from Atlanta Braves' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.27%	13.00%	-72.27%	21.76%	-9.03%	28.01%	5.87%	0.00%	0.00%	0.00%
EBITDA Growth	9.72%	10.34%	-73.64%	323.68%	-72.56%	2.49%	11.20%	169.78%	0.00%	-100.00%
EBIT Growth	30.13%	30.86%	-81.40%	571.68%	-126.87%	-6.55%	13.34%	139.18%	0.00%	-100.00%
NOPAT Growth	8.24%	-4.25%	-90.00%	1,404.64%	-87.54%	-20.80%	-60.59%	227.20%	0.00%	-100.00%
Net Income Growth	-357.28%	-52.59%	172.72%	153.49%	-500.86%	-59.88%	-54.23%	153.24%	0.00%	0.00%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	-12.78%	9.69%	-76.28%	40.87%	-25.21%	7.28%	24.48%	-20.22%	0.00%	0.00%
Free Cash Flow Firm Growth	-98.23%	1,781.02%	-6.01%	-7.99%	416.69%	-158.82%	102.73%	-242.55%	6,542.57%	-67.52%
Invested Capital Growth	-2.84%	-74.23%	-3.29%	1.47%	-3.97%	4.43%	1.39%	0.00%	-100.00%	-1.32%
Revenue Q/Q Growth	-20.55%	3,261.06%	-74.18%	-23.29%	27.16%	-24.88%	5.87%	339.86%	0.00%	0.00%
EBITDA Q/Q Growth	-55.64%	147.66%	-76.11%	-50.62%	169.62%	-66.29%	50.45%	123.04%	0.00%	-100.00%
EBIT Q/Q Growth	-66.12%	126.22%	-84.25%	-61.76%	52.04%	-77.37%	107.44%	113.43%	0.00%	-100.00%
NOPAT Q/Q Growth	-89.02%	114.60%	-88.16%	-62.12%	121.27%	-84.84%	63.91%	143.61%	0.00%	-100.00%
Net Income Q/Q Growth	-125.82%	70.27%	64.42%	-79.75%	38.83%	-93.35%	-19.31%	120.21%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-12.22%	208.93%	-76.92%	3.83%	8.19%	0.96%	5.02%	-5.56%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-98.28%	14,130.57%	-41.93%	-72.87%	2,291.21%	-110.88%	436.21%	-86.27%	3,524.28%	-77.58%
Invested Capital Q/Q Growth	-1.63%	-73.49%	-1.45%	-0.07%	-1.97%	0.18%	2.51%	4.36%	-100.00%	-0.75%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.89%	37.29%	44.64%	52.13%	51.37%	53.16%	55.46%	56.27%	0.00%	0.00%
EBITDA Margin	25.95%	24.19%	24.77%	26.05%	7.49%	24.83%	31.01%	29.52%	0.00%	0.00%
Operating Margin	7.56%	7.14%	4.59%	17.34%	1.89%	14.28%	18.79%	18.36%	0.00%	0.00%
EBIT Margin	16.32%	12.82%	11.07%	16.51%	-4.26%	14.43%	19.76%	18.46%	0.00%	0.00%
Profit (Net Income) Margin	-67.75%	26.93%	64.19%	6.53%	-14.86%	3.37%	10.76%	24.89%	0.00%	0.00%
Tax Burden Percent	10,312.50%	-3,848.00%	286.99%	94.30%	96.93%	67.64%	83.09%	228.54%	100.00%	0.00%
Interest Burden Percent	-4.03%	-5.46%	202.00%	41.92%	359.65%	34.55%	65.51%	58.99%	99.22%	0.00%
Effective Tax Rate	0.00%	0.00%	-28.57%	5.70%	0.00%	32.36%	16.91%	-128.54%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.34%	0.87%	0.56%	5.58%	0.37%	2.94%	3.82%	19.52%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	55.95%	66.74%	13.60%	-2.31%	-11.19%	-2.45%	0.18%	-6.24%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-21.02%	4.12%	10.13%	-1.71%	-7.07%	-1.35%	0.09%	-2.78%	0.00%	0.00%
Return on Equity (ROE)	-18.68%	4.99%	10.69%	3.87%	-6.70%	1.59%	3.91%	16.74%	-39.16%	0.00%
Cash Return on Invested Capital (CROIC)	5.21%	118.92%	3.91%	4.12%	4.42%	-1.40%	2.45%	-180.48%	178.37%	1.33%
Operating Return on Assets (OROA)	2.20%	1.09%	0.81%	4.26%	-0.90%	3.49%	3.84%	6.68%	0.00%	0.00%
Return on Assets (ROA)	-9.12%	2.30%	4.67%	1.68%	-3.15%	0.82%	2.09%	9.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-16.52%	4.18%	8.63%	3.00%	-5.06%	1.20%	2.96%	12.57%	-23.61%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-35.21%	5.87%	12.71%	5.07%	-9.22%	2.13%	5.21%	11.16%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	193	179	186	1,864	124	994	1,256	3,186	-2,505	0.00
NOPAT Margin	5.29%	5.00%	5.90%	16.35%	1.32%	9.66%	15.62%	41.95%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-53.61%	-65.87%	-13.04%	7.89%	11.56%	5.39%	3.64%	25.76%	41.55%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.67%	0.75%	0.52%	5.06%	0.33%	2.66%	3.58%	8.72%	0.00%	0.00%
Cost of Revenue to Revenue	68.11%	62.71%	55.36%	47.87%	48.63%	46.84%	44.54%	43.73%	0.00%	0.00%
SG&A Expenses to Revenue	11.47%	11.09%	12.43%	19.58%	22.56%	21.69%	20.51%	21.68%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.34%	30.15%	40.05%	34.79%	49.48%	38.87%	36.63%	37.91%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	596	458	350	1,882	-399	1,485	1,589	1,402	-3,578	0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	948	864	783	2,970	701	2,555	2,493	2,242	-3,213	0.00
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.07	2.31	2.00	2.18	1.57	1.61	1.09	1.19	0.00	1.20
Price to Tangible Book Value (P/TBV)	138.89	3.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	7.83	10.60	10.12	2.81	2.53	2.55	2.25	2.65	0.00	0.00
Price to Earnings (P/E)	0.00	49.74	17.62	80.43	0.00	247.18	34.12	14.87	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	2.01%	5.68%	1.24%	0.00%	0.40%	2.93%	6.73%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.65	5.13	1.49	1.52	1.26	1.29	1.05	1.10	0.00	1.09
Enterprise Value to Revenue (EV/Rev)	8.14	12.05	15.37	4.47	4.46	4.32	4.30	4.72	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	31.36	49.81	62.03	17.17	59.59	17.40	13.88	15.98	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	49.89	93.97	138.78	27.10	0.00	29.94	21.78	25.55	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	153.90	241.10	260.54	27.36	337.14	44.71	27.56	11.24	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	53.77	67.88	84.04	20.93	24.15	19.22	16.05	20.68	6.76	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	68.96	1.77	37.52	37.04	27.91	0.00	43.07	0.00	0.71	81.50
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.22	0.87	0.99	0.89	0.71	0.62	0.62	0.00	0.38
Long-Term Debt to Equity	0.64	0.21	0.78	0.83	0.85	0.70	0.62	0.58	0.00	0.37
Financial Leverage	-0.38	0.06	0.74	0.74	0.63	0.55	0.48	0.45	0.28	0.22
Leverage Ratio	2.05	2.17	2.29	2.30	2.12	1.95	1.87	1.86	1.64	1.57
Compound Leverage Factor	-0.08	-0.12	4.62	0.96	7.64	0.67	1.23	1.10	1.63	0.00
Debt to Total Capital	39.21%	17.84%	46.51%	49.67%	47.07%	41.38%	38.16%	38.20%	0.00%	27.51%
Short-Term Debt to Total Capital	0.22%	0.45%	4.70%	7.72%	2.01%	0.16%	0.05%	2.10%	0.00%	1.02%
Long-Term Debt to Total Capital	38.99%	17.39%	41.82%	41.95%	45.06%	41.22%	38.11%	36.10%	0.00%	26.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.19%	12.88%	8.85%	11.13%	12.18%	15.05%	14.54%	15.42%	0.00%	28.78%
Common Equity to Total Capital	60.60%	69.28%	44.64%	39.20%	40.75%	43.57%	47.30%	46.38%	0.00%	43.71%
Debt to EBITDA	4.80	4.89	21.24	6.26	24.86	6.06	5.37	6.22	0.00	0.00
Net Debt to EBITDA	1.16	2.47	17.16	4.99	19.37	4.94	4.57	4.49	0.00	0.00
Long-Term Debt to EBITDA	4.77	4.77	19.10	5.29	23.80	6.03	5.36	5.88	0.00	0.00
Debt to NOPAT	23.54	23.66	89.21	9.97	140.67	15.56	10.66	4.38	0.00	0.00
Net Debt to NOPAT	5.70	11.97	72.06	7.96	109.60	12.70	9.07	3.16	0.00	0.00
Long-Term Debt to NOPAT	23.41	23.06	80.21	8.42	134.67	15.50	10.65	4.14	0.00	0.00
Altman Z-Score	4.33	1.63	1.36	1.50	1.14	1.45	1.30	1.29	0.00	1.11
Noncontrolling Interest Sharing Ratio	11.59%	16.11%	19.30%	22.57%	24.42%	24.60%	24.25%	24.94%	39.70%	41.71%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.95	0.71	0.71	0.73	0.90	0.62	0.33	0.44	0.00	0.25
Quick Ratio	2.71	0.39	0.57	0.55	0.81	0.51	0.22	0.35	0.00	0.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	431	24,349	1,294	1,377	1,497	-473	804	-29,449	20,658	311
Operating Cash Flow to CapEx	0.00%	181.14%	277.88%	4,275.44%	394.08%	3,401.47%	53,900.00%	349.19%	429.05%	0.00%
Free Cash Flow to Firm to Interest Expense	1.82	98.18	6.96	2.15	2.36	-0.72	1.33	-49.83	0.00	0.00
Operating Cash Flow to Interest Expense	2.33	2.56	3.11	3.80	2.73	3.52	3.56	2.93	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	2.51	1.15	1.99	3.71	2.04	3.42	3.55	2.09	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.13	0.09	0.07	0.26	0.21	0.24	0.19	0.36	0.00	0.00
Accounts Receivable Turnover	30.83	7.44	3.80	13.81	11.78	18.20	22.27	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	4.43	2.31	1.48	5.37	4.16	4.35	3.21	0.00	0.00	0.00
Accounts Payable Turnover	4.43	1.92	0.95	3.20	2.84	3.52	3.03	0.00	0.00	0.00
Days Sales Outstanding (DSO)	11.84	49.05	96.13	26.43	30.99	20.06	16.39	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	82.30	189.83	384.61	114.21	128.43	103.61	120.58	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	-70.46	-140.78	-288.48	-87.78	-97.44	-83.55	-104.19	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,152	8,390	32,560	33,668	33,181	34,554	33,087	32,635	0.00	23,163
Invested Capital Turnover	0.44	0.17	0.10	0.34	0.28	0.30	0.24	0.47	0.00	0.00
Increase / (Decrease) in Invested Capital	-238	-24,170	-1,108	487	-1,373	1,467	452	32,635	-23,163	-311
Enterprise Value (EV)	29,734	43,036	48,573	51,008	41,772	44,460	34,609	35,819	14,678	25,348
Market Capitalization	28,611	37,851	31,976	32,012	23,682	26,201	18,117	20,127	14,678	13,118
Book Value per Share	$20.65	$25.12	$26.03	$23.90	$24.21	$27.23	$27.22	$27.54	$0.00	$32.71
Tangible Book Value per Share	$0.61	$14.68	($28.76)	($31.54)	($31.27)	($32.73)	($28.18)	($28.13)	$0.00	($42.43)
Total Capital	11,599	23,668	35,758	37,427	37,030	37,401	35,086	36,528	0.00	25,012
Total Debt	4,548	4,223	16,632	18,590	17,429	15,476	13,388	13,954	0.00	6,881
Total Long-Term Debt	4,522	4,117	14,953	15,699	16,686	15,416	13,371	13,186	0.00	6,626
Net Debt	1,101	2,136	13,434	14,831	13,580	12,629	11,389	10,061	0.00	5,032
Capital Expenditures (CapEx)	-42	350	208	57	439	68	4.00	496	506	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-716	-2,973	-2,126	-1,721	-2,548	-2,645	-2,503	-2,497	0.00	-2,068
Debt-free Net Working Capital (DFNWC)	2,240	-1,260	120	1,093	283	-1,423	-2,145	-1,468	0.00	-1,867
Net Working Capital (NWC)	2,214	-1,366	-1,559	-1,798	-460	-1,483	-2,162	-2,236	0.00	-2,122
Net Nonoperating Expense (NNE)	2,668	-784	-1,843	1,120	1,515	647	391	1,296	1,045	0.00
Net Nonoperating Obligations (NNO)	1,101	-11,055	13,434	14,831	13,580	12,629	11,389	10,061	0.00	5,032
Total Depreciation and Amortization (D&A)	352	406	433	1,088	1,100	1,070	904	840	365	0.00
Debt-free, Cash-free Net Working Capital to Revenue	-19.60%	-83.23%	-67.26%	-15.10%	-27.21%	-25.70%	-31.13%	-32.88%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	61.32%	-35.27%	3.80%	9.59%	3.02%	-13.83%	-26.68%	-19.33%	0.00%	0.00%
Net Working Capital to Revenue	60.61%	-38.24%	-49.32%	-15.77%	-4.91%	-14.41%	-26.89%	-29.44%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$2.54	$3.94	$1.79	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	341.10M	652.95M	613.48M	617.67M	622.12M	598.17M	605.44M	0.00	586.70M	334.64M
Adjusted Diluted Earnings per Share	$0.00	$2.42	$3.66	$1.78	($6.90)	($1.33)	$1.46	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	341.10M	652.95M	613.48M	617.67M	622.12M	598.17M	605.44M	0.00	586.70M	334.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	341.10M	652.95M	613.48M	617.67M	622.12M	598.17M	605.44M	0.00	586.70M	334.64M
Normalized Net Operating Profit after Tax (NOPAT)	267	179	106	1,883	827	1,051	1,256	976	-3,220	0.00
Normalized NOPAT Margin	7.30%	5.02%	3.34%	16.52%	8.83%	10.21%	15.62%	12.85%	0.00%	0.00%
Pre Tax Income Margin	-0.66%	-0.70%	22.37%	6.92%	-15.33%	4.98%	12.95%	10.89%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.51	1.85	1.88	2.93	-0.63	2.26	2.62	2.37	0.00	0.00
NOPAT to Interest Expense	0.82	0.72	1.00	2.90	0.20	1.51	2.07	5.39	0.00	0.00
EBIT Less CapEx to Interest Expense	2.69	0.44	0.76	2.84	-1.32	2.16	2.62	1.53	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.99	-0.69	-0.12	2.82	-0.50	1.41	2.07	4.55	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	7.80%	-4.60%	19.60%	6.82%	3.17%	-0.45%	0.00%
Augmented Payout Ratio	0.00%	0.00%	1.82%	287.10%	-139.25%	769.45%	212.60%	77.72%	-47.61%	0.00%

This table displays calculated financial ratios and metrics derived from Atlanta Braves' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-100.00%	-42.41%	0.00%	-2.40%	7.55%	62.32%	-100.00%	-0.43%	-0.51%	-286.53%	4.74%
EBITDA Growth	-438.07%	-197.29%	101.99%	-3.80%	24.34%	141.47%	-260.88%	2.11%	-19.89%	-342.10%	-14.22%
EBIT Growth	-846.67%	-229.58%	120.49%	-3.47%	48.26%	143.80%	-293.09%	3.76%	-30.36%	-414.16%	-18.44%
NOPAT Growth	-985.16%	-196.90%	112.15%	-0.49%	124.54%	164.39%	-321.13%	-1.14%	-49.92%	-370.06%	-20.55%
Net Income Growth	-374.29%	-134.93%	-591.57%	67.33%	371.15%	63.52%	-195.62%	-55.04%	-82.43%	467.65%	8.50%
EPS Growth	0.00%	0.00%	0.00%	22.45%	36.84%	0.00%	0.00%	-60.48%	0.00%	0.00%	-19.61%
Operating Cash Flow Growth	190.84%	-142.59%	7.61%	40.04%	-40.24%	104.65%	-219.08%	-19.85%	19.96%	-252.09%	18.49%
Free Cash Flow Firm Growth	2,494.23%	-101.47%	4,301.99%	42.59%	-3.10%	17,359.15%	-48.92%	22.82%	95.83%	209.82%	61.75%
Invested Capital Growth	-74.65%	-2.84%	-73.81%	-3.93%	-2.58%	-74.23%	-4.22%	-2.30%	-3.26%	-3.29%	-1.94%
Revenue Q/Q Growth	100.00%	-448.30%	-71.23%	15.17%	223.38%	0.00%	-100.00%	26.92%	143.23%	-282.11%	-0.34%
EBITDA Q/Q Growth	17.02%	-2,572.41%	-96.72%	17.84%	1.90%	150.62%	-258.26%	52.32%	133.99%	-296.35%	0.44%
EBIT Q/Q Growth	16.63%	-419.84%	-60.63%	25.49%	-18.01%	150.57%	-285.52%	92.73%	124.23%	-322.92%	-0.31%
NOPAT Q/Q Growth	21.95%	-676.07%	-75.65%	10.40%	-37.43%	172.24%	-299.40%	149.11%	117.94%	-348.09%	-10.85%
Net Income Q/Q Growth	-88.24%	87.56%	-666.08%	106.94%	-76.03%	346.27%	-236.96%	482.69%	-91.68%	44.01%	-35.61%
EPS Q/Q Growth	0.00%	0.00%	0.00%	15.38%	0.00%	0.00%	0.00%	28.95%	0.00%	0.00%	-33.87%
Operating Cash Flow Q/Q Growth	1,756.52%	95.97%	-175.93%	90.38%	631.48%	108.74%	-215.08%	-18.76%	156.88%	-323.89%	-22.54%
Free Cash Flow Firm Q/Q Growth	6,403.43%	-101.55%	1,277.17%	39.39%	-95.07%	4,551.41%	-55.39%	-5.28%	788.26%	-86.39%	7.26%
Invested Capital Q/Q Growth	-2.28%	-1.63%	-73.41%	-0.82%	274.55%	-73.49%	-2.45%	0.57%	-0.93%	-1.45%	-0.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	34.69%	44.54%	52.13%	0.00%	0.00%	51.23%	51.88%	0.00%	52.73%
EBITDA Margin	0.00%	0.00%	3.18%	27.95%	27.32%	0.00%	0.00%	28.36%	23.63%	0.00%	27.87%
Operating Margin	0.00%	0.00%	11.75%	16.68%	18.26%	0.00%	0.00%	16.12%	13.30%	0.00%	15.58%
EBIT Margin	0.00%	0.00%	27.66%	20.21%	18.55%	0.00%	0.00%	20.44%	13.46%	0.00%	19.62%
Profit (Net Income) Margin	0.00%	0.00%	-315.04%	16.01%	8.91%	0.00%	0.00%	9.34%	2.03%	0.00%	13.37%
Tax Burden Percent	100.00%	32.51%	-2,125.93%	81.38%	77.53%	138.86%	33.74%	82.56%	50.98%	-56.26%	76.95%
Interest Burden Percent	100.00%	136.23%	53.57%	97.34%	61.96%	118.33%	100.00%	55.35%	29.65%	78.24%	88.54%
Effective Tax Rate	0.00%	0.00%	2.22%	18.62%	22.47%	0.00%	0.00%	17.44%	49.02%	0.00%	23.05%
Return on Invested Capital (ROIC)	0.00%	0.00%	2.64%	1.57%	1.67%	0.00%	0.00%	1.27%	0.65%	0.00%	4.40%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-42.31%	2.21%	0.52%	0.00%	0.00%	0.33%	-0.22%	0.00%	4.72%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-20.97%	1.35%	0.33%	0.00%	0.00%	0.24%	-0.16%	0.00%	3.46%
Return on Equity (ROE)	0.00%	0.00%	-18.33%	2.93%	2.01%	0.00%	2.95%	1.51%	0.49%	0.00%	7.86%
Cash Return on Invested Capital (CROIC)	117.37%	5.21%	125.80%	5.12%	3.79%	118.92%	0.53%	2.30%	3.42%	3.91%	6.68%
Operating Return on Assets (OROA)	0.00%	0.00%	4.65%	1.75%	1.65%	0.00%	0.00%	1.49%	0.98%	0.00%	5.48%
Return on Assets (ROA)	0.00%	0.00%	-52.94%	1.39%	0.79%	0.00%	0.00%	0.68%	0.15%	0.00%	3.73%
Return on Common Equity (ROCE)	0.00%	0.00%	-16.26%	2.47%	1.69%	0.00%	2.44%	1.24%	0.40%	0.00%	6.17%
Return on Equity Simple (ROE_SIMPLE)	-48.20%	0.00%	-14.74%	7.97%	6.98%	0.00%	3.48%	8.68%	11.18%	0.00%	8.05%
Net Operating Profit after Tax (NOPAT)	-470	-603	105	430	389	622	-861	432	173	-966	389
NOPAT Margin	0.00%	0.00%	11.48%	13.57%	14.16%	0.00%	0.00%	13.31%	6.78%	0.00%	11.99%
Net Nonoperating Expense Percent (NNEP)	3.18%	4.94%	44.95%	-0.64%	1.16%	-33.63%	-3.38%	0.94%	0.87%	-11.26%	-0.32%
Return On Investment Capital (ROIC_SIMPLE)	-4.05%	-5.20%	0.88%	1.22%	1.11%	2.63%	-2.47%	1.22%	0.49%	-2.70%	1.08%
Cost of Revenue to Revenue	0.00%	0.00%	65.31%	55.46%	47.87%	0.00%	0.00%	48.77%	48.12%	0.00%	47.27%
SG&A Expenses to Revenue	0.00%	0.00%	12.73%	17.25%	20.19%	0.00%	0.00%	17.97%	22.54%	0.00%	18.82%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	22.94%	27.86%	32.92%	0.00%	0.00%	35.11%	38.58%	0.00%	37.14%
Earnings before Interest and Taxes (EBIT)	-672	-806	252	640	510	622	-1,230	663	344	-1,420	637
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-595	-717	29	885	751	737	-1,456	920	604	-1,777	905
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.95	4.07	6.30	2.46	2.32	2.31	1.95	1.97	2.00	2.00	2.08
Price to Tangible Book Value (P/TBV)	102.54	138.89	96.15	0.00	0.00	3.95	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	9.06	7.83	10.18	11.38	10.19	10.60	0.00	10.22	10.16	10.12	2.61
Price to Earnings (P/E)	0.00	0.00	0.00	36.40	40.41	49.74	76.45	26.23	20.12	17.62	31.25
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	2.75%	2.47%	2.01%	1.31%	3.81%	4.97%	5.68%	3.20%
Enterprise Value to Invested Capital (EV/IC)	3.61	3.65	5.75	1.80	1.69	5.13	1.49	1.49	1.50	1.49	1.50
Enterprise Value to Revenue (EV/Rev)	9.37	8.14	10.37	15.21	14.14	12.05	0.00	15.37	15.34	15.37	4.05
Enterprise Value to EBITDA (EV/EBITDA)	0.00	31.36	22.31	57.46	52.64	49.81	0.00	73.90	76.29	62.03	15.14
Enterprise Value to EBIT (EV/EBIT)	0.00	49.89	27.11	93.31	85.29	93.97	0.00	215.10	241.45	138.78	22.34
Enterprise Value to NOPAT (EV/NOPAT)	0.00	153.90	27.11	158.54	142.73	241.10	0.00	0.00	1,363.19	260.54	31.52
Enterprise Value to Operating Cash Flow (EV/OCF)	35.76	53.77	75.68	96.19	144.62	67.88	0.00	86.81	70.19	84.04	19.83
Enterprise Value to Free Cash Flow (EV/FCFF)	1.24	68.96	1.90	34.45	44.13	1.77	275.42	63.79	42.98	37.52	22.27
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.65	0.59	0.74	0.79	0.22	0.81	0.84	0.86	0.87	0.92
Long-Term Debt to Equity	0.64	0.64	0.58	0.71	0.73	0.21	0.77	0.80	0.82	0.78	0.90
Financial Leverage	0.48	-0.38	0.50	0.61	0.64	0.06	0.69	0.72	0.74	0.74	0.73
Leverage Ratio	2.09	2.05	2.05	2.15	2.19	2.17	2.21	2.26	2.31	2.29	2.28
Compound Leverage Factor	2.09	2.79	1.10	2.10	1.36	2.57	2.21	1.25	0.68	1.79	2.02
Debt to Total Capital	39.27%	39.21%	36.92%	42.65%	44.01%	17.84%	44.88%	45.69%	46.21%	46.51%	47.98%
Short-Term Debt to Total Capital	0.26%	0.22%	0.64%	1.94%	3.38%	0.45%	2.37%	2.22%	1.99%	4.70%	1.36%
Long-Term Debt to Total Capital	39.01%	38.99%	36.27%	40.71%	40.63%	17.39%	42.51%	43.47%	44.22%	41.82%	46.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.19%	0.19%	0.19%	8.93%	8.82%	12.88%	8.57%	8.44%	8.80%	8.85%	10.13%
Common Equity to Total Capital	60.54%	60.60%	62.89%	48.42%	47.17%	69.28%	46.55%	45.87%	44.99%	44.64%	41.89%
Debt to EBITDA	-31.26	4.80	2.04	15.40	15.27	4.89	-8.64	24.88	25.90	21.24	5.36
Net Debt to EBITDA	-6.21	1.16	0.39	11.23	11.65	2.47	-6.84	20.19	20.81	17.16	4.27
Long-Term Debt to EBITDA	-31.05	4.77	2.01	14.70	14.10	4.77	-8.18	23.67	24.79	19.10	5.21
Debt to NOPAT	-13.33	23.54	2.48	42.49	41.41	23.66	-12.81	-2,106.36	462.85	89.21	11.15
Net Debt to NOPAT	-2.65	5.70	0.47	30.98	31.59	11.97	-10.14	-1,709.35	371.90	72.06	8.88
Long-Term Debt to NOPAT	-13.25	23.41	2.44	40.55	38.24	23.06	-12.13	-2,004.16	442.92	80.21	10.83
Altman Z-Score	3.70	3.97	6.31	1.75	1.60	1.64	1.23	1.41	1.38	1.22	1.57
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	11.29%	15.55%	16.05%	0.00%	17.51%	17.67%	18.58%	0.00%	21.47%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.54	2.95	2.89	0.81	0.66	0.71	0.78	0.74	0.79	0.71	0.95
Quick Ratio	2.28	2.71	2.49	0.65	0.50	0.39	0.62	0.57	0.64	0.57	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	22,989	-365	23,463	1,704	1,222	24,792	533	1,195	1,261	142	1,043
Operating Cash Flow to CapEx	1,154.55%	-176.92%	0.00%	951.90%	196.52%	45.76%	0.00%	233.48%	267.61%	0.00%	524.24%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	378.43	9.16	6.40	0.00	0.00	5.97	6.44	0.00	5.83
Operating Cash Flow to Interest Expense	0.00	0.00	-9.21	4.04	2.07	0.00	0.00	2.69	3.37	0.00	2.90
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-3.81	3.62	1.02	0.00	0.00	1.54	2.11	0.00	2.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.13	0.17	0.09	0.09	0.09	0.00	0.07	0.07	0.07	0.28
Accounts Receivable Turnover	6.57	30.83	9.89	4.47	5.05	7.44	0.00	3.81	4.08	3.80	14.95
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.08	4.43	3.25	1.58	1.66	2.31	0.00	1.31	1.43	1.48	5.81
Accounts Payable Turnover	2.90	4.43	1.76	1.42	1.44	1.92	0.89	1.04	1.15	0.95	3.74
Days Sales Outstanding (DSO)	55.54	11.84	36.91	81.57	72.22	49.05	0.00	95.79	89.39	96.13	24.41
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	125.68	82.30	207.36	257.11	253.74	189.83	410.38	352.20	317.55	384.61	97.58
Cash Conversion Cycle (CCC)	-70.15	-70.46	-170.44	-175.53	-181.52	-140.78	0.00	-256.41	-228.15	-288.48	-73.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,966	8,152	8,287	31,167	31,425	8,390	31,645	32,441	32,258	32,560	33,039
Invested Capital Turnover	0.16	0.44	0.23	0.12	0.12	0.17	0.00	0.10	0.10	0.10	0.37
Increase / (Decrease) in Invested Capital	-23,459	-238	-23,358	-1,274	-833	-24,170	-1,394	-763	-1,088	-1,108	-654
Enterprise Value (EV)	28,718	29,734	47,678	56,078	53,221	43,036	47,124	48,181	48,289	48,573	49,644
Market Capitalization	27,789	28,611	46,827	41,971	38,347	37,851	31,726	32,024	31,993	31,976	31,939
Book Value per Share	$20.63	$20.65	$11.36	$26.11	$25.33	$25.12	$28.95	$26.52	$26.02	$26.03	$25.04
Tangible Book Value per Share	$0.79	$0.61	$0.74	($24.50)	($25.37)	$14.68	($29.76)	($27.82)	($28.55)	($28.76)	($30.01)
Total Capital	11,623	11,599	11,824	35,235	35,087	23,668	34,902	35,498	35,480	35,758	36,609
Total Debt	4,564	4,548	4,365	15,028	15,442	4,223	15,663	16,219	16,396	16,632	17,565
Total Long-Term Debt	4,534	4,522	4,289	14,343	14,257	4,117	14,836	15,432	15,690	14,953	17,066
Net Debt	907	1,101	828	10,960	11,780	2,136	12,406	13,162	13,174	13,434	13,995
Capital Expenditures (CapEx)	33	13	-335	79	201	118	-245	230	247	-198	99
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-896	-716	-572	-2,233	-2,152	-2,973	-2,336	-2,403	-2,479	-2,126	-2,237
Debt-free Net Working Capital (DFNWC)	2,251	2,240	2,482	-148	-486	-1,260	-224	-472	-250	120	305
Net Working Capital (NWC)	2,221	2,214	2,406	-833	-1,671	-1,366	-1,051	-1,259	-956	-1,559	-194
Net Nonoperating Expense (NNE)	202	-246	2,975	-77	144	-400	-446	129	121	-1,591	-45
Net Nonoperating Obligations (NNO)	907	1,101	828	10,960	11,780	-11,055	12,406	13,162	13,174	13,434	13,995
Total Depreciation and Amortization (D&A)	77	89	-223	245	241	115	-226	257	260	-357	268
Debt-free, Cash-free Net Working Capital to Revenue	-29.22%	-19.60%	-12.44%	-60.56%	-57.16%	-83.23%	0.00%	-76.68%	-78.75%	-67.26%	-18.27%
Debt-free Net Working Capital to Revenue	73.42%	61.32%	53.98%	-4.01%	-12.91%	-35.27%	0.00%	-15.06%	-7.94%	3.80%	2.49%
Net Working Capital to Revenue	72.44%	60.61%	52.33%	-22.59%	-44.38%	-38.24%	0.00%	-40.17%	-30.37%	-49.32%	-1.58%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.91	$0.61	$0.00	$0.94	$0.51	$0.00	$0.00	$0.93
Adjusted Weighted Average Basic Shares Outstanding	341.29M	341.10M	340.44M	654.64M	653.45M	652.95M	652.83M	561.13M	614.08M	613.48M	613.15M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.60	$0.52	$0.00	$0.89	$0.49	$0.00	$0.00	$0.82
Adjusted Weighted Average Diluted Shares Outstanding	341.29M	341.10M	340.44M	654.64M	653.45M	652.95M	652.83M	561.13M	614.08M	613.48M	613.15M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	341.29M	341.10M	340.44M	654.64M	653.45M	652.95M	652.83M	561.13M	614.08M	613.48M	613.15M
Normalized Net Operating Profit after Tax (NOPAT)	-455	-603	108	442	406	435	-861	447	190	-966	446
Normalized NOPAT Margin	0.00%	0.00%	11.81%	13.96%	14.78%	0.00%	0.00%	13.79%	7.42%	0.00%	13.75%
Pre Tax Income Margin	0.00%	0.00%	14.82%	19.68%	11.50%	0.00%	0.00%	11.31%	3.99%	0.00%	17.37%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	4.06	3.44	2.67	0.00	0.00	3.32	1.76	0.00	3.56
NOPAT to Interest Expense	0.00	0.00	1.69	2.31	2.04	0.00	0.00	2.16	0.88	0.00	2.18
EBIT Less CapEx to Interest Expense	0.00	0.00	9.47	3.02	1.62	0.00	0.00	2.17	0.49	0.00	3.01
NOPAT Less CapEx to Interest Expense	0.00	0.00	7.09	1.89	0.99	0.00	0.00	1.01	-0.38	0.00	1.62
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	20.26%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-14.64%	-5.37%	0.00%	0.00%	-37.84%	-21.34%	1.82%	141.82%

Frequently Asked Questions About Atlanta Braves' Financials

When does Atlanta Braves's financial year end?

According to the most recent income statement we have on file, Atlanta Braves' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Atlanta Braves' net income changed over the last 9 years?

Atlanta Braves' net income appears to be on a downward trend, with a most recent value of -$2.48 billion in 2024, falling from $0.00 in 2015. The previous period was $962 million in 2023. Check out Atlanta Braves' forecast to explore projected trends and price targets.

What is Atlanta Braves's operating income?

Atlanta Braves's total operating income in 2024 was $276 million, based on the following breakdown:

Total Gross Profit: $1.17 billion
Total Operating Expenses: $889 million

How has Atlanta Braves revenue changed over the last 9 years?

Over the last 9 years, Atlanta Braves' total revenue changed from $0.00 in 2015 to $3.65 billion in 2024, a change of 365,300,000,000.0%.

How much debt does Atlanta Braves have?

Atlanta Braves' total liabilities were at $5.90 billion at the end of 2024, a 73.1% decrease from 2023, and a 49.5% decrease since 2015.

How much cash does Atlanta Braves have?

In the past 9 years, Atlanta Braves' cash and equivalents has ranged from $0.00 in 2016 to $2.96 billion in 2024, and is currently $2.96 billion as of their latest financial filing in 2024.

How has Atlanta Braves' book value per share changed over the last 9 years?

Over the last 9 years, Atlanta Braves' book value per share changed from 32.71 in 2015 to 20.65 in 2024, a change of -36.9%.

Related Companies

This page (NASDAQ:BATRA) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Atlanta Braves (BATRA) Financials

Frequently Asked Questions About Atlanta Braves' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Atlanta Braves (BATRA) Financials

Annual Income Statements for Atlanta Braves

Quarterly Income Statements for Atlanta Braves

Annual Cash Flow Statements for Atlanta Braves

Quarterly Cash Flow Statements for Atlanta Braves

Annual Balance Sheets for Atlanta Braves

Quarterly Balance Sheets for Atlanta Braves

Annual Metrics And Ratios for Atlanta Braves

Quarterly Metrics And Ratios for Atlanta Braves

Frequently Asked Questions About Atlanta Braves' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools